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Abstract
1) The contents of sialic acid in patients of various diseases sera were determined and in-
creases of it were noticed in several diseases. 2) Sialic acid contents ranged between 50 and 100
mg./dl. in the normal serum. 3) But in the pathological serum, it ranged between 90 and 170
mg./dl. in cancer patients, between 80 and 110 mg./dl. in peptic ulcer, between 75 and 135 mg./dl.
in arachnoiditis, and between 90 and 120 mg./dl. in epilepsy. 4) In other several diseases, sialic
acid contents were determined.
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In 1936, BLIX1 isolated from submaxillary mucin a crystalline which
produces with BIAL's orcinol reagent violet pigment soluble in amylalcohol.
Lately, it was given the name' Sialic acid' by WERNER and ODIN.
Recently many kinds of similar substances were isolated from diffe-
rent sources. All these substances possess the common characteristics of
forming purple color not only with BIAL'S orcinol reagent but also with
EHRLICH'S aldehyde and DISH'S diphenylamine reagents. These sub-
stances have been dassified and reviewed by YAMAKAWA2 •
NIAZI and STATE3 demonstrated increased color intensity of serum of
malignant tumor patients with diphenylamine reagent. WERNER and
OOIN supposed it to be due to sialic acid.
YAMAKAWA et al.4isolated sero·lactamic acid as a Bial-chromogen from
horse serum mucoprotein in crystalline form, and reported the contents of
it in various kinds of animal sera and a patients sera of various diseases.
On the other hand, BbHN6,7,8 isolated methoxyl·neuramic acid in
crystalline form, and reported the neuramic acid contents in many kinds
of patients sera.
SAITO et al.9 also reported the sialic acid contents in patients sera.
In their report, determination was carried out according to WERNER
and OOIN's principle, using p-dimethylaminobenzaldehyde and dipheny-
lamine reagents.
In our department likewise sialic acid contents in the various patients
sera, mainly in surgical diseases, were determined. We present also a
report on blood counts and blood chemistry in these cases.
EXPERIMENTAL METHOD
Sialic acid standard sample: Sialic acid from human serum was ge-
nerously contributed by Dr. YAMAKAWA. Method of determination: YA-
MAKAWA, SUZUKI and AKITA'S4,S method modifying WERNER and OOIN'S
original method using BIAL'S reagent was used, i.e., 0.05 ml. of serum was
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NameISe+.e Isialicl B. S. R'j Ecytb_' Leuco.l Bleed. Hb cou-Is T
Protein
No. Diagnosis acid 1-2 rocyte cyte ing tents pecI. IC
con-
mg/dl hours counts counts time % gravity tentsg/dl
1 T.M. If- 24 Normal 67
2 K.M. If- 21
"
99
3 T. F. If- 22
"
64
4 Y. Y. If- 23 .. 96
5 K. S. If- 20
"
65
6 H.O. If- 24
"
51
7 Y. Y. 0 28
"
90
8 Y. S. 0 30 It 75
9 S.M. 0 26
"
82
10 I. E. 0 48 Stomach carcinoma 120 45-97 270x 1()4 6500 2' 60 1022 6.3
11 R.H. 0 39 .. 140 37-62 252 6200 2'30" 63 1024 6.35
12 T.A. 0 55 It 108 50-85 368 9000 3' 75 1024 6.4
13 R.H. 0 39
"
151 22-45 324 9800 1'30" 78 1026 7.0
14 J. N. 0 65 Rectal carcinoma 112 2-10 414 5400 2' 84 1024 6.1
15 T.H. 0 53 Liver carcinoma 110 100-107414 9800 2' 68 1025 6.7
16 K. S. 0 63 Carcinoma of gallbladder 158 70-110(75 9400 2'30" 85 1024 5.8
17 R. Y. If- 50 Carcinoma of left maxilla 90 15-30 375 5800 1'30" 54 1023 6.0
18 A.K. 0 73 Bronchiogenous carcinoma 102 72-122304 6200 2' 62 1022 6.3
19 M. S. If- 50 Intestinal obstruction due to retroperitoneal 156 5-12 365 6500 3' 75 1026 7.1
20 K.A. o 120 Susp. of phaeochromocytoma
tumor 94 2-14 513 6700 2'15" 68 1029 7.8
21 K. S. If- 40 Brain tumor 158 12-31 364 5800 2' 68 1028 7.8
22 M.T. If- 37 .. 135 75-98 405 7400 2' 76 1028 7.8
23 Y. S. 0 40 It 100 5-10 392 6800 2'30" 80 1028 ·7.8
24 I. H. 0 41 .. 100 19-20 380 7600 2' 82 1028 7.8
25 K. I. If- 43 .. 122 5-10 343 5600 5' 72 1028 7.85
26 M.Y. 0 48
"
90 10-29 370 5600 3'30" 75 1027 7.5
27 K.K. 0 39 .. 113 23-49 350 7000 2'30" 60 1028 7.8
28 H.A. If- 37 .. 164 66-90 310 5300 2'30" 65 1026 7.0
29 K.M. 0 25 Gastric ulcer 141 136-150270 8000 2' 45 1027 7.4
30 Y. S. If- 57 .. 105 35-60 1282 4200 1'30" 62 1026'" 7.2
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Sia.Iicl B. S. R'I Eryth-I Leuco-I Bleed-IHb con-I~ "j Protein
aCId 1-2 rocyte cyte ing tents SpecI.ft~ con-
mg/dl hours counts counts time % gravIty tentsg/dl
l'V
U1
o
80
108
103
97
96
95
60
99
90
88
114
96
104
130
133
75
118
62
92
113
124
123
131
141
80
96
162
165
92
116
140
22-441304 X 1()4
20-43 100
18-26 378
12-25 412
10-24 420
3-10 440
12-40 430
1-3 375
1-3 352
20-40 319
8-13 420
7-17 520
7-10 319
12-38 412
30-75 412
28-62 477
12-25 420
5-14 532
44-72 380
9-21 495
20-31 475
18-40 362
20-42 302
72-41 471
17-41 485
15-35 465
80-110385
17-25 350
11-35 365
13-27 390
25-55 511
5200
3000
4800
5600
5800
6400
5600
6800
7200
8000
8200
6700
6200
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8400
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6100
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3'
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pipetted in glass-stoppered tube, to which 4.95 ml. of water, 3.5 ml. of
orcinol reagent and FeCb reagent were added and mixed, and heated ex-
actly for 10 minutes in saturated NaCI solution at 108°C. After cooling
in running water, 5 ml. of pure iso-amylalcohol was added and the mixture
was vigorously shaken in an ice-bath. After centrifugation, the clear
supernant was removed with' a pipette to a cuvette and the optical density
was measured against blank with a BECKMAN'S electrophotometer using
570 mfl..
RESULTS AND DISCUSSION
Sialic acid contents ranged between 50 and 100 mg./d!. in normal
sera, but between 90 and 170 mg./dl. in the sera of cancer patients. In
peptic ulcer, it ranged between 80 and 110 mg./dl.
In the SAITO's report, sialic acid contents level in serum seems to be
too high. On this point, AKITA10 reports the determination by BIAL'S
reagent is more stable and correct than the other methods.
In epilepsy, sialic acid contents ranged between 90 and 120 mg./dl.,
and it is quite interesting, while very few chemical changes have been
found in the epileptic diseases.
Generally it is already known that the high sialic acid values are ob-
tained in the inflammatory diseases. In our experiences, it ranged be-
tween 75-135 mg./dl. in arachnoiditis.
In other diseases, the cases are too few to draw any definite conclu-
sion.
On the other hand, no special relation with blood counts or other
blood chemistry could be recognized in our determination.
CONCLUSIONS
1) The contents of sialic acid in patients of various diseases sera
were determined and increases of it were noticed in several diseases.
2) Sialic acid contents ranged between 50 and 100 mg./ dl. in the
normal serum.
3) But in the pathological serum, it ranged between 90 and 170 mg.
/dl. in cancer patients, between 80 and 110 mg./dl. in peptic ulcer, be-
tween 75 and 135 mg./ d!. in arachnoiditis, and between 90 and 120 mg./ dl.
in epilepsy.
4) In other several diseases, sialic acid contents were determined.
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